{
    "pmcid": "9257560",
    "qa_pairs": {
        "What is a key advantage of nanobodies mentioned in the study regarding their production and use?": [
            "They are inexpensive to produce and accessible for widespread use.",
            "They are capable of self-replication in host cells.",
            "They can be stored indefinitely without degradation.",
            "They require no purification before use in assays."
        ],
        "What method was used to map the epitopes of P86 and P17 on the spike protein?": [
            "Cryo-electron microscopy (cryo-EM)",
            "X-ray crystallography",
            "Nuclear magnetic resonance (NMR) spectroscopy",
            "Mass spectrometry"
        ],
        "What potential application of nanobodies is suggested by their ability to detect spike proteins in various assays?": [
            "Use in diagnostic kits, such as ELISA and lateral flow assays.",
            "Development of vaccines targeting the spike protein.",
            "Creation of antiviral drugs that inhibit spike protein synthesis.",
            "Engineering of spike protein-based biosensors for environmental monitoring."
        ],
        "What was a limitation identified for the C246 clone in the study?": [
            "It did not neutralize authentic SARS-CoV-2 virus infection.",
            "It was unable to bind to the spike protein in ELISA assays.",
            "It showed no binding to the Omicron variant.",
            "It was unstable at physiological temperatures."
        ],
        "Which specific nanobody was highlighted for its ability to neutralize Omicron variants by targeting conserved epitopes?": [
            "P86",
            "C246",
            "P17",
            "N123"
        ]
    }
}